Ardelyx

ARDX Small Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$5.94

-2.78% heute

52W: $3.21 – $8.40

52W Low: $3.21 Position: 52.6% 52W High: $8.40

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

11.38x

Erwartetes KGV

P/S Ratio

3.58x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$1.5B

Marktkapitalisierung

Umsatzwachstum

7.8%

YoY Umsatzwachstum

Gewinnmarge

-15.12%

Nettomarge

ROE

-36.21%

Eigenkapitalrendite

Beta

0.66

Marktsensitivität

Short Interest

9.99%

% der Aktien leerverkauft

Ø Volumen

4,646,508

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

10 Analysten

Ø Kursziel

$16.10

+171.04% Upside

Kursziel Spanne

$13.00 – $19.00

Über das Unternehmen

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 489 Börse: NGM

Trading-Daten

50-Day MA: $6.53

200-Day MA: $5.76

Volumen: 2,398,323

Ø Volumen: 4,646,508

Short Ratio: 5.02

Kurs/Buchwert: 8.7x

Verschuldung/EK: 140.06x

Free Cash Flow: $6.8M

Wo kann ich Ardelyx kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →